|
|
DGAPAdhoc: PAION AG / Key words: Contract
PAION GRANTS EXCLUSIVE LICENSE TO CRISTÁLIA FOR DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN LATIN AMERICA
27Apr2022 / 16:33 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by DGAP a service of EQS Group AG.
The issuer is solely responsible for... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: PAION AG
/ Key words: Personnel
PAION AG ANNOUNCES CHANGE IN MANAGEMENT BOARD
30.03.2022 / 10:00
The issuer is solely responsible for the content of this announcement.
PAION AG ANNOUNCES CHANGE IN MANAGEMENT BOARD
Sebastian Werner to succeed Abdelghani Omari as Chief Financial Office... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: PAION AG
/ Key words: Annual Results
PAION AG REPORTS ON FISCAL YEAR 2021
30.03.2022 / 07:30
The issuer is solely responsible for the content of this announcement.
PAION AG REPORTS ON FISCAL YEAR 2021
Transformation into com... Lire le communiqué |
|
| |
|
| |
|
|
OriginalResearch: PAION AG von First Berlin Equity Research GmbH
Einstufung von First Berlin Equity Research GmbH zu PAION AG
Unternehmen: PAION AG
ISIN: DE000A0B65S3
Anlass der Studie: Update
Empfehlung: Kaufen
seit: 31.01.2022
Kursziel: €3,80
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung:
Analyst: Simon Scholes, CFA
First Berlin Equity Resea... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: PAION AG
/ Key words: Personnel
PAION AG ANNOUNCES CHANGE IN SUPERVISORY BOARD
27.01.2022 / 15:00
The issuer is solely responsible for the content of this announcement.
PAION AG ANNOUNCES CHANGE IN SUPERVISORY BOARD
Michael Schlenk to succeed Dr. Dr. Irina Antonijevic and to become candida... Lire le communiqué |
|
| |
|
| |
|
|
DGAPAdhoc: PAION AG / Schlagworte: Vertrag
PAION ÜBERTRÄGT CHINESISCHE REMIMAZOLAMPATENTE UND VERKAUFT DAMIT VERBUNDENE ZUKÜNFTIGE LIZENZGEBÜHREN FÜR EUR 20,5 MIO. AN HUMANWELL HEALTHCARE GROUP
07.01.2022 / 13:59 CET/CEST
Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung EU Nr.... Lire le communiqué |
|
| |
|
| |
|
|
DGAPAdhoc: PAION AG / Key words: Contract
PAION ASSIGNS CHINESE REMIMAZOLAM PATENTS AND SELLS RELATED FUTURE ROYALTIES FOR EUR 20.5 MILLION TO HUMANWELL HEALTHCARE GROUP
07Jan2022 / 13:59 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by DGAP a service of EQS Gr... Lire le communiqué |
|
| |
|
| |
